Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Immunol ; 199(4): 1342-1352, 2017 08 15.
Artículo en Inglés | MEDLINE | ID: mdl-28710254

RESUMEN

Ocular infection with HSV causes a chronic T cell-mediated inflammatory lesion in the cornea. Lesion severity is affected by the balance of different CD4 T cell subsets, with greater severity occurring when the activity of regulatory T cells (Tregs) is compromised. In this study, fate-mapping mice were used to assess the stability of Treg function in ocular lesions. We show that cells that were once Foxp3+ functional Tregs may lose Foxp3 and become Th1 cells that could contribute to lesion expression. The instability primarily occurred with IL-2Rlo Tregs and was shown, in part, to be the consequence of exposure to IL-12. Lastly, in vitro-generated induced Tregs (iTregs) were shown to be highly plastic and capable of inducing stromal keratitis when adoptively transferred into Rag1-/- mice, with 95% of iTregs converting into ex-Tregs in the cornea. This plasticity of iTregs could be prevented when they were generated in the presence of vitamin C and retinoic acid. Importantly, adoptive transfer of these stabilized iTregs to HSV-1-infected mice prevented the development of stromal keratitis lesions more effectively than did control iTregs. Our results demonstrate that CD25lo Treg and iTreg instability occurs during a viral immunoinflammatory lesion and that its control may help to avoid lesion chronicity.


Asunto(s)
Plasticidad de la Célula , Córnea/inmunología , Córnea/patología , Herpesvirus Humano 1/inmunología , Queratitis Herpética/inmunología , Linfocitos T Reguladores/inmunología , Células TH1/inmunología , Traslado Adoptivo , Animales , Ácido Ascórbico/farmacología , Linfocitos T CD4-Positivos/inmunología , Diferenciación Celular , Córnea/virología , Femenino , Factores de Transcripción Forkhead/análisis , Proteínas de Homeodominio/genética , Interleucina-12/inmunología , Interleucina-12/metabolismo , Subunidad alfa del Receptor de Interleucina-2/genética , Subunidad alfa del Receptor de Interleucina-2/inmunología , Queratitis Herpética/fisiopatología , Queratitis Herpética/virología , Activación de Linfocitos , Ratones , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/fisiología , Linfocitos T Reguladores/efectos de los fármacos , Linfocitos T Reguladores/fisiología , Células TH1/fisiología , Tretinoina/farmacología
2.
Proc Natl Acad Sci U S A ; 113(8): 2235-40, 2016 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-26858424

RESUMEN

Plasmodium infections result in clinical presentations that range from asymptomatic to severe malaria, resulting in ∼1 million deaths annually. Despite this toll on humanity, the factors that determine disease severity remain poorly understood. Here, we show that the gut microbiota of mice influences the pathogenesis of malaria. Genetically similar mice from different commercial vendors, which exhibited differences in their gut bacterial community, had significant differences in parasite burden and mortality after infection with multiple Plasmodium species. Germfree mice that received cecal content transplants from "resistant" or "susceptible" mice had low and high parasite burdens, respectively, demonstrating the gut microbiota shaped the severity of malaria. Among differences in the gut flora were increased abundances of Lactobacillus and Bifidobacterium in resistant mice. Susceptible mice treated with antibiotics followed by yogurt made from these bacterial genera displayed a decreased parasite burden. Consistent with differences in parasite burden, resistant mice exhibited an elevated humoral immune response compared with susceptible mice. Collectively, these results identify the composition of the gut microbiota as a previously unidentified risk factor for severe malaria and modulation of the gut microbiota (e.g., probiotics) as a potential treatment to decrease parasite burden.


Asunto(s)
Microbioma Gastrointestinal , Malaria/microbiología , Animales , Antibacterianos/uso terapéutico , Bifidobacterium/aislamiento & purificación , Bifidobacterium/fisiología , Microbioma Gastrointestinal/inmunología , Microbioma Gastrointestinal/fisiología , Vida Libre de Gérmenes , Interacciones Huésped-Parásitos/inmunología , Humanos , Lactobacillus/aislamiento & purificación , Lactobacillus/fisiología , Malaria/parasitología , Malaria/terapia , Ratones , Ratones Endogámicos C57BL , Carga de Parásitos , Plasmodium yoelii , Probióticos/uso terapéutico
3.
J Immunol ; 194(2): 697-708, 2015 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-25505280

RESUMEN

Plasmodium remains a major pathogen causing malaria and impairing defense against other infections. Defining how Plasmodium increases susceptibility to heterologous pathogens may lead to interventions that mitigate the severity of coinfections. Previous studies proposed that reduced T cell responses during coinfections are due to diminished recruitment of naive T cells through infection-induced decreases in chemokine CCL21. We found that, although Listeria infections reduced expression of CCL21 in murine spleens, lymphocytic choriomeningitis virus (LCMV)-specific T cell responses were not impaired during Listeria + LCMV coinfection, arguing against a major role for this chemokine in coinfection-induced T cell suppression. In our experiments, Plasmodium yoelii infection led to a reduced CD8(+) T cell response to a subsequent Listeria infection. We propose an alternative mechanism whereby P. yoelii suppresses Listeria-specific T cell responses. We found that Listeria-specific T cells expanded more slowly and resulted in lower numbers in response to coinfection with P. yoelii. Mathematical modeling and experimentation revealed greater apoptosis of Listeria-specific effector T cells as the main mechanism, because P. yoelii infections did not suppress the recruitment or proliferation rates of Listeria-specific T cells. Our results suggest that P. yoelii infections suppress immunity to Listeria by causing increased apoptosis in Listeria-specific T cells, resulting in a slower expansion rate of T cell responses.


Asunto(s)
Coinfección/inmunología , Inmunidad Celular , Listeria monocytogenes/inmunología , Listeriosis/inmunología , Malaria/inmunología , Plasmodium yoelii/inmunología , Linfocitos T/inmunología , Animales , Apoptosis/inmunología , Quimiocina CCL21/genética , Quimiocina CCL21/inmunología , Coinfección/genética , Coinfección/microbiología , Coinfección/parasitología , Coinfección/patología , Listeriosis/genética , Listeriosis/parasitología , Listeriosis/patología , Malaria/genética , Malaria/microbiología , Malaria/patología , Ratones , Ratones Transgénicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA